Crescita Therapeutics Inc Cash Flow Quality Index
Crescita Therapeutics Inc cash flow quality index. Crescita Therapeutics Inc (CTX) has a Cash Flow Quality Index of 1.56x as of September 2025. Operating cash flow of CA$1.17 Million exceeds net income of CA$753.00K, indicating high earnings quality where cash backs reported profits. See Crescita Therapeutics Inc (CTX) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Crescita Therapeutics Inc (2018–2022)
Cash flow quality index of Crescita Therapeutics Inc from 2018 to 2022. Historical Cash Flow Quality Index for Crescita Therapeutics Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Crescita Therapeutics Inc (CTX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Crescita Therapeutics Inc Cash Flow Quality Index by Year (2018–2022)
Crescita Therapeutics Inc cash flow quality index by year from 2018 to 2022. Year-by-year earnings quality comparison for Crescita Therapeutics Inc. For the full cash flow conversion analysis, see CTX cash flow metrics.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -1.18x | CA$-1.02 Million | CA$862.00K | ▼ -100.8% |
| 2020 | 151.57x | CA$5.61 Million | CA$37.00K | ▲ +5198.9% |
| 2019 | 2.86x | CA$5.31 Million | CA$1.85 Million | ▲ +563.7% |
| 2018 | -0.62x | CA$-1.48 Million | CA$2.40 Million | — |